Phase I Study of Quizartinib Administered Daily to Patients With Relapsed or Refractory Acute Myeloid Leukemia Irrespective of FMS-Like Tyrosine Kinase 3–Internal Tandem Duplication Status
CORTES, Jorge E, KANTARJIAN, Hagop, LEVIS, Mark, FORAN, James M, GHIRDALADZE, Darejan, ZODELAVA, Mamia, BORTHAKUR, Gautam, GAMMON, Guy, TRONE, Denise, ARMSTRONG, Robert C, JAMES, Joyce
Published in Journal of clinical oncology (10.10.2013)
Published in Journal of clinical oncology (10.10.2013)
Get full text
Journal Article
Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy
Harrison, Claire N, Garcia, Jacqueline S, Somervaille, Tim C P, Foran, James M, Verstovsek, Srdan, Jamieson, Catriona, Mesa, Ruben, Ritchie, Ellen K, Tantravahi, Srinivas K, Vachhani, Pankit, O'Connell, Casey L, Komrokji, Rami S, Harb, Jason, Hutti, Jessica E, Holes, Leanne, Masud, Abdullah A, Nuthalapati, Silpa, Potluri, Jalaja, Pemmaraju, Naveen
Published in Journal of clinical oncology (20.05.2022)
Published in Journal of clinical oncology (20.05.2022)
Get full text
Journal Article
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML
Swords, Ronan T., Coutre, Steven, Maris, Michael B., Zeidner, Joshua F., Foran, James M., Cruz, Jose, Erba, Harry P., Berdeja, Jesus G., Tam, Wayne, Vardhanabhuti, Saran, Pawlikowska-Dobler, Iwona, Faessel, Hélène M., Dash, Ajeeta B., Sedarati, Farhad, Dezube, Bruce J., Faller, Douglas V., Savona, Michael R.
Published in Blood (29.03.2018)
Published in Blood (29.03.2018)
Get full text
Journal Article
Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies
Ansell, Stephen M, Maris, Michael B, Lesokhin, Alexander M, Chen, Robert W, Flinn, Ian W, Sawas, Ahmed, Minden, Mark D, Villa, Diego, Percival, Mary-Elizabeth M, Advani, Anjali S, Foran, James M, Horwitz, Steven M, Mei, Matthew G, Zain, Jasmine, Savage, Kerry J, Querfeld, Christiane, Akilov, Oleg E, Johnson, Lisa D S, Catalano, Tina, Petrova, Penka S, Uger, Robert A, Sievers, Eric L, Milea, Anca, Roberge, Kathleen, Shou, Yaping, O'Connor, Owen A
Published in Clinical cancer research (15.04.2021)
Published in Clinical cancer research (15.04.2021)
Get full text
Journal Article
Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study
Nowakowski, Grzegorz S, LaPlant, Betsy, Macon, William R, Reeder, Craig B, Foran, James M, Nelson, Garth D, Thompson, Carrie A, Rivera, Candido E, Inwards, David J, Micallef, Ivana N, Johnston, Patrick B, Porrata, Luis F, Ansell, Stephen M, Gascoyne, Randy D, Habermann, Thomas M, Witzig, Thomas E
Published in Journal of clinical oncology (20.01.2015)
Published in Journal of clinical oncology (20.01.2015)
Get full text
Journal Article
Venetoclax plus hypomethylating agent in blast‐phase myeloproliferative neoplasm: preliminary experience with 12 patients
Gangat, Naseema, Morsia, Erika, Foran, James M., Palmer, Jeanne M., Elliott, Michelle A., Tefferi, Ayalew
Published in British journal of haematology (01.12.2020)
Published in British journal of haematology (01.12.2020)
Get full text
Journal Article
Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia
Altman, Jessica K., Foran, James M., Pratz, Keith W., Trone, Denise, Cortes, Jorge E., Tallman, Martin S.
Published in American journal of hematology (01.02.2018)
Published in American journal of hematology (01.02.2018)
Get full text
Journal Article
Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial
Burd, Amy, Levine, Ross L., Ruppert, Amy S., Mims, Alice S., Borate, Uma, Stein, Eytan M., Patel, Prapti, Baer, Maria R., Stock, Wendy, Deininger, Michael, Blum, William, Schiller, Gary, Olin, Rebecca, Litzow, Mark, Foran, James, Lin, Tara L., Ball, Brian, Boyiadzis, Michael, Traer, Elie, Odenike, Olatoyosi, Arellano, Martha, Walker, Alison, Duong, Vu. H., Kovacsovics, Tibor, Collins, Robert, Shoben, Abigail B., Heerema, Nyla A., Foster, Matthew C., Vergilio, Jo-Anne, Brennan, Tim, Vietz, Christine, Severson, Eric, Miller, Molly, Rosenberg, Leonard, Marcus, Sonja, Yocum, Ashley, Chen, Timothy, Stefanos, Mona, Druker, Brian, Byrd, John C.
Published in Nature medicine (01.12.2020)
Published in Nature medicine (01.12.2020)
Get full text
Journal Article
Venetoclax with azacitidine or decitabine in blast‐phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases
Gangat, Naseema, Guglielmelli, Paola, Szuber, Natasha, Begna, Kebede H., Patnaik, Mrinal M., Litzow, Mark R., Al‐Kali, Aref, Foran, James M., Palmer, Jeanne M., Alkhateeb, Hassan, Elliott, Michelle A., Hanson, Curtis A., Pardanani, Animesh, Mannelli, Francesco, Vannucchi, Alessandro M., Tefferi, Ayalew
Published in American journal of hematology (01.07.2021)
Published in American journal of hematology (01.07.2021)
Get full text
Journal Article
A phase I/II multicenter, open-label, dose escalation and randomized trial of BI 836858 in patients with low- or intermediate-1-risk myelodysplastic syndrome
Komrokji, Rami S, Carraway, Hetty E, Germing, Ulrich, Wermke, Martin, Zeidan, Amer M, Fu, Eric, Rüter, Björn, Burkard, Ute, Osswald, Annika, Foran, James M
Published in Haematologica (Roma) (01.11.2022)
Published in Haematologica (Roma) (01.11.2022)
Get full text
Journal Article
Activity of the oral mitogen‐activated protein kinase kinase inhibitor trametinib in RAS‐mutant relapsed or refractory myeloid malignancies
Borthakur, Gautam, Popplewell, Leslie, Boyiadzis, Michael, Foran, James, Platzbecker, Uwe, Vey, Norbert, Walter, Roland B., Olin, Rebecca, Raza, Azra, Giagounidis, Aristoteles, Al‐Kali, Aref, Jabbour, Elias, Kadia, Tapan, Garcia‐Manero, Guillermo, Bauman, John W., Wu, Yuehui, Liu, Yuan, Schramek, Dan, Cox, Donna S., Wissel, Paul, Kantarjian, Hagop
Published in Cancer (15.06.2016)
Published in Cancer (15.06.2016)
Get full text
Journal Article
Clinical and molecular correlates of somatic and germline DDX41 variants in patients and families with myeloid neoplasms
Badar, Talha, Nanaa, Ahmad, Foran, James M, Viswanatha, David, Al-Kali, Aref, Lasho, Terra, Finke, Christy, Alkhateeb, Hassan B, He, Rong, Gangat, Naseema, Shah, Mithun, Tefferi, Ayalew, Mangaonkar, Abhishek A, Litzow, Mark R, Ongie, Laura J, Chlon, Timothy, Ferrer, Alejandro, Patnaik, Mrinal M
Published in Haematologica (Roma) (01.11.2023)
Published in Haematologica (Roma) (01.11.2023)
Get full text
Journal Article
Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era
Tao, Li, Foran, James M., Clarke, Christina A., Gomez, Scarlett L., Theresa Keegan, H.M.
Published in Blood (05.06.2014)
Published in Blood (05.06.2014)
Get full text
Journal Article
Venetoclax plus hypomethylating agents in DDX41-mutated acute myeloid leukaemia and myelodysplastic syndrome: Mayo Clinic series on 12 patients
Nanaa, Ahmad, He, Rong, Foran, James M, Badar, Talha, Gangat, Naseema, Pardanani, Animesh, Hogan, William J, Litzow, Mark R, Patnaik, Mrinal, Al-Kali, Aref, Alkhateeb, Hassan B
Published in British journal of haematology (01.01.2024)
Published in British journal of haematology (01.01.2024)
Get full text
Journal Article
Outcomes of TP53‐mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival
Badar, Talha, Atallah, Ehab, Shallis, Rory M., Goldberg, Aaron D., Patel, Anand, Abaza, Yasmin, Bewersdorf, Jan P., Saliba, Antoine N., Correia, Guilherme Sacchi De Camargo, Murthy, Guru, Duvall, Adam, Burkart, Madelyn, Stahl, Maximilian, Liu, Yuanhang, Dinner, Shira, Palmisiano, Neil, Litzow, Mark R., Foran, James M.
Published in American journal of hematology (01.07.2022)
Published in American journal of hematology (01.07.2022)
Get full text
Journal Article
Limited activity of fedratinib in myelofibrosis patients relapsed/refractory to ruxolitinib 20 mg twice daily or higher: A real‐world experience
Gangat, Naseema, McCullough, Kristen, Al‐Kali, Aref, Begna, Kebede H., Patnaik, Mrinal M., Litzow, Mark R., Hogan, William, Shah, Mithun, Alkhateeb, Hassan, Mangaonkar, Abhishek, Foran, James M., Palmer, Jeanne M., Pardanani, Animesh, Tefferi, Ayalew
Published in British journal of haematology (01.08.2022)
Published in British journal of haematology (01.08.2022)
Get full text
Journal Article
FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)( DEK::NUP214 ): the Mayo Clinic experience
Csizmar, Clifford M, Saliba, Antoine N, Greipp, Patricia T, Alkhateeb, Hassan, Begna, Kebede H, Foran, James M, Gangat, Naseema, Hogan, William J, Hook, C Christopher, Litzow, Mark R, Mangaonkar, Abhishek A, Palmer, Jeanne M, Pardanani, Animesh, Shah, Mithun V, Tefferi, Ayalew, Torghabeh, Mehrdad Hefazi, Wolanskyj-Spinner, Alexandra P, Patnaik, Mrinal M, Kaufmann, Scott H, Al-Kali, Aref
Published in Haematologica (Roma) (01.11.2024)
Published in Haematologica (Roma) (01.11.2024)
Get full text
Journal Article